Comparing treatments for opioid use disorder in pregnant women
Official title: The Comparative Effectiveness and Safety of Pharmacotherapies for the Treatment of Opioid Use Disorder in Pregnancy
Funded at Brigham and Women's Hospital · NIH-11194370 · Data updated 2026-11-12
This study is looking at how well different medications for opioid use disorder work and how safe they are for pregnant women and their babies, with the goal of finding better ways to support moms-to-be who are dealing with this issue.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Brigham and Women's Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project start | April 1, 2020 |
| Project end | May 31, 2029 |
| Funding year | 2025 |
| Award (this year) | $763,288 |
| NIH project number | 5R01DA049822-06 |
| Project ID | NIH-11194370 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are pregnant women diagnosed with opioid use disorder who are receiving or considering medication-assisted treatment.
✕Less likely to help
Patients who are not pregnant or those without a diagnosis of opioid use disorder may not benefit from this research.
What this research studies
This research investigates the effectiveness and safety of different medications used to treat opioid use disorder (OUD) in pregnant women. It aims to understand how treatments like buprenorphine and methadone impact both maternal and fetal health, particularly in relation to risks such as neonatal abstinence syndrome and preterm delivery. The study also examines the challenges of maintaining treatment during and after pregnancy, especially in the presence of other substance use disorders. By analyzing these factors, the research seeks to improve treatment strategies for pregnant patients with OUD.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment protocols that enhance the health outcomes for both mothers and their babies.
How similar studies have gone: Previous research has shown promising results in comparing different medications for opioid use disorder, indicating that this approach has potential for significant findings.
Where this research is happening
-
Brigham and Women's Hospital
Boston, United States Active
Researchers
- Principal investigator: Huybrechts, Krista F — Brigham and Women's Hospital
- Study coordinator: Huybrechts, Krista F
Related research
Other NIH-funded projects on the same topics.
-
Big data insights to improve opioid-use disorder treatment during pregnancy
A skilled clinician-researcher is using large health data to understand which FDA-approved meds for opioid use disorder work best for pregnant people and how access to care affects safety and outcomes.
-
Fetal brain health markers in pregnant people exposed to opioids
A study of fetal brain health using baby’s circulating RNA carriers in the blood of pregnant people with opioid exposure to help identify which infants may need early treatment.
-
Comparing safety and effectiveness of opioid-use disorder medicines for pregnant people
This project looks at how different medications for opioid use disorder work for people who are pregnant, aiming to understand which options are safer and more effective for both mom and baby.
-
Understanding Fetal Brain Health in Pregnancies with Opioid Use
This research aims to find ways to predict which babies exposed to opioids during pregnancy might develop Neonatal Abstinence Syndrome (NAS) by looking at tiny particles from the baby's brain in the mother's blood.
-
Improving treatment for pregnant women with opioid use disorder in jails
This study is working to make sure that pregnant women in jail who are dealing with opioid use disorder get the right medication and care they need, so both they and their babies can be healthier.
-
Optimizing opioid treatment for pregnant individuals using big data
This study is looking at how to make treatment for opioid use disorder better for pregnant people, especially in Black communities, by checking how well medications like buprenorphine and methadone are prescribed and used.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.